Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn Stamford develops role as business hub

The University of Connecticut maintains its headquarters upstate, but its brand is quickly growing in the state’s southwestern corner. University officials are intent on expanding...

| By Kelley Gipson

Sema4 names Oh Chief Medical Science Officer

Sema4 has named William K. Oh, M.D., to the newly established senior leadership position of Chief Medical Science Officer. Dr. Oh, who was previously Chair of...

| By Kelley Gipson

Thetis completes Pre-IND meeting with FDA

Thetis Pharmaceuticals has completed a Pre-IND (Investigational New Drug) meeting with the FDA for its lead candidate, TP-317, a Resolvin E1 oral, small molecule therapy...

| By Kelley Gipson

Taconic expands immuno-oncology portfolio

Immuno-oncology uses the body’s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role because they use...

| By Kelley Gipson

Cara Therapeutics wins 2020 Marcum Tech Top 40

Marcum LLP has announced the winners of the 2020 Marcum Tech Top 40, an annual program recognizing the fastest growing technology and life sciences companies in...

| By Kelley Gipson

BioCT welcomes Catalyst Clinical Research

Catalyst Clinical Research is a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry through two established solutions: Catalyst Flex...

| By Kelley Gipson

Azitra eyes ‘milestone year’ in 2021

A Branford startup is betting its future on the trillions of bacteria, viruses, fungi and mites that live peacefully on human skin. Azitra, a growing...

| By Kelley Gipson

Branford’s IsoPlexis closes on $135M

Branford medical technology company IsoPlexis said it has secured $135 million in new financing that it will use in part to expand its commercial and...